Home
»
The Billing Beat Newsletter
»
BCBS Kansas – Medical Policy Updates
BCBS Kansas – Medical Policy Updates
February 12, 2024
Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Breast Cancer (BRCA1, BRCA2, PIK3CA, Ki-67, RET, BRAF, ESR1)
Homocysteine Testing
Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk
Testing Serum Vitamin D Levels
Source:
https://www.bcbsks.com/providers/medical-policies
BCBS
Payor
Sign up for Billing Beat
